English

NORTH AMERICAN VACCINE INC

EDGAR

Quarterly report (10-Q) · filed 2000-05-15

20 filing records in this dataset, filed from 1996-05-15 to 2000-05-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

526 thousand USD

2000-03-31 · USD

Exact inputs and evidence

Revenue: 526000 USD Source

Operating margin

-2,524.9%

2000-03-31 · %

Exact inputs and evidence

Operating Income: -13281000 USD Source
Revenue: 526000 USD Source

Operating cash flow

-8.95 million USD

2000-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -8952000 USD Source

Free cash flow

-9.1 million USD

2000-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -8952000 USD Source
Capital Expenditure: 149000 USD Source

Cash and cash equivalents: 937 thousand USD 2000-03-31 Source
Exact value

937000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

9.96 million USD

1999-04-01 – 2000-03-31

Exact inputs and evidence

Revenue: 1680000 USD · 1999-04-01 – 1999-06-30 Source
Revenue: 4422000 USD · 1999-07-01 – 1999-09-30 Source
Revenue: 10958000 USD · 1999-01-01 – 1999-12-31 Source
Revenue: 7626000 USD · 1999-01-01 – 1999-09-30 Source
Revenue: 526000 USD · 2000-01-01 – 2000-03-31 Source

Net income

-54.6 million USD

1999-04-01 – 2000-03-31

Exact inputs and evidence

Net income: -12990000 USD · 1999-04-01 – 1999-06-30 Source
Net income: -10821000 USD · 1999-07-01 – 1999-09-30 Source
Net income: -49573000 USD · 1999-01-01 – 1999-12-31 Source
Net income: -34066000 USD · 1999-01-01 – 1999-09-30 Source
Net income: -15303000 USD · 2000-01-01 – 2000-03-31 Source

Operating cash flow

-38 million USD

1999-04-01 – 2000-03-31

Exact inputs and evidence

Operating cash flow: -20617000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -9945000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -26036000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -20617000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -38960000 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: -26036000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -8952000 USD · 2000-01-01 – 2000-03-31 Source

Capital expenditure

2.11 million USD

1999-04-01 – 2000-03-31

Exact inputs and evidence

Capital expenditure: 1814000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 1134000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 2686000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 1814000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 3091000 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 2686000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 149000 USD · 2000-01-01 – 2000-03-31 Source

Free cash flow

-40.1 million USD

1999-04-01 – 2000-03-31

Exact inputs and evidence

Operating cash flow: -20617000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -9945000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -26036000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -20617000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -38960000 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: -26036000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -8952000 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 1814000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 1134000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 2686000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 1814000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 3091000 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 2686000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 149000 USD · 2000-01-01 – 2000-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-05-15.

Financial data available through: 1999-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1999-12-31
Operating income: 6 of 11 periods available· newest 1999-12-31
Net income: 6 of 11 periods available· newest 1999-12-31
Operating cash flow: 6 of 11 periods available· newest 1999-12-31
Capital expenditure: 6 of 11 periods available· newest 1999-12-31
Total assets: 5 of 11 periods available· newest 1999-12-31
Total liabilities: 5 of 11 periods available· newest 1999-12-31
Current assets: 5 of 11 periods available· newest 1999-12-31
Current liabilities: 5 of 11 periods available· newest 1999-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1999-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+30.8%

Prior period

USD 8.38 million

1998-01-01 – 1998-12-31
Current period

USD 10.96 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

10958000 − 8379000 = 2579000 USD

8379000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
10958000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Year-over-year change in Revenue: 2579000 USD Concept: fundies:Revenue Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 10958000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#3932 Input fundies:Revenue: 8379000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#3932
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 7.04 million

Prior period

−USD 56.61 million

1998-01-01 – 1998-12-31
Current period

−USD 49.57 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-49573000 − -56609000 = 7036000 USD

-56609000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-49573000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Year-over-year change in Net income: 7036000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -49573000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4066 Input fundies:NetIncome: -56609000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4066
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.5 million

Prior period

−USD 40.46 million

1998-01-01 – 1998-12-31
Current period

−USD 38.96 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-38960000 − -40457000 = 1497000 USD

-40457000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-38960000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Year-over-year change in Operating cash flow: 1497000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -38960000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085 Input fundies:OperatingCashFlow: -40457000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+37.7%

Prior period

USD 2.25 million

1998-01-01 – 1998-12-31
Current period

USD 3.09 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

3091000 − 2245000 = 846000 USD

2245000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
3091000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Year-over-year change in Capital expenditure: 846000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3091000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089 Input fundies:CapitalExpenditure: 2245000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1999-01-01 – 1999-12-31

Revenue USD 10.96 million 100% of revenue
Operating costs Derived USD 52.03 million 475% of revenue
Operating income −USD 41.07 million −375% of revenue
Tax, interest and other Derived USD 8.5 million 78% of revenue
Net income −USD 49.57 million −452% of revenue

Cash

Operating cash flow −USD 38.96 million −356% of revenue
Capital expenditure USD 3.09 million 28% of revenue
Free cash flow Derived −USD 42.05 million −384% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Operating loss: operating costs were 774% of revenue.
1996 Operating loss: operating costs were 314% of revenue.
1997 Operating loss: operating costs were 515% of revenue.
1998 Operating loss: operating costs were 573% of revenue.
1999 Operating loss: operating costs were 475% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	0	16494000 Derived	-16494000	-12567000 Derived	-3927000	-14946000 Derived	Source 1994-01-01 – 1994-12-31: 0 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -16494000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -3927000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -8569000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 6377000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	3000000	23219000 Derived	-20219000	-15233000 Derived	-4986000	-27695000 Derived	Source 1995-01-01 – 1995-12-31: 3000000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -20219000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -4986000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -17416000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 10279000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	10548000	33111000 Derived	-22563000	-3074000 Derived	-19489000	-39921000 Derived	Source 1996-01-01 – 1996-12-31: 10548000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -22563000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -19489000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -18909000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 21012000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	9700000	49908000 Derived	-40208000	3632000 Derived	-43840000	-27045000 Derived	Source 1997-01-01 – 1997-12-31: 9700000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -40208000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -43840000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -24913000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 2132000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	8379000	47982000 Derived	-39603000	17006000 Derived	-56609000	-42702000 Derived	Source 1998-01-01 – 1998-12-31: 8379000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -39603000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -56609000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -40457000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 2245000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	10958000	52029000 Derived	-41071000	8502000 Derived	-49573000	-42051000 Derived	Source 1999-01-01 – 1999-12-31: 10958000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -41071000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -49573000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -38960000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 3091000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 11M 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	0	Revenue: 0 Open source
19951995-12-31	Revenue	3000000	Revenue: 3000000 Open source
19961996-12-31	Revenue	10548000	Revenue: 10548000 Open source
19971997-12-31	Revenue	9700000	Revenue: 9700000 Open source
19981998-12-31	Revenue	8379000	Revenue: 8379000 Open source
19991999-12-31	Revenue	10958000	Revenue: 10958000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

30.8% 1999

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19951995-12-31	Year over year	No prior comparable period	Revenue: 3000000 Open source Revenue: 0 Open source
19961996-12-31	Year over year	251.6%	Revenue: 10548000 Open source Revenue: 3000000 Open source
19971997-12-31	Year over year	-8%	Revenue: 9700000 Open source Revenue: 10548000 Open source
19981998-12-31	Year over year	-13.6%	Revenue: 8379000 Open source Revenue: 9700000 Open source
19991999-12-31	Year over year	30.8%	Revenue: 10958000 Open source Revenue: 8379000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -374.8% 1999

Net margin -452.4% 1999

Free cash flow margin -383.7% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	Not reported	Operating Income: -16494000 Open source Revenue: 0 Open source
19951995-12-31	Operating margin	-674%	Operating Income: -20219000 Open source Revenue: 3000000 Open source
19961996-12-31	Operating margin	-213.9%	Operating Income: -22563000 Open source Revenue: 10548000 Open source
19971997-12-31	Operating margin	-414.5%	Operating Income: -40208000 Open source Revenue: 9700000 Open source
19981998-12-31	Operating margin	-472.6%	Operating Income: -39603000 Open source Revenue: 8379000 Open source
19991999-12-31	Operating margin	-374.8%	Operating Income: -41071000 Open source Revenue: 10958000 Open source
19941994-12-31	Net margin	Not reported	Net Income: -3927000 Open source Revenue: 0 Open source
19951995-12-31	Net margin	-166.2%	Net Income: -4986000 Open source Revenue: 3000000 Open source
19961996-12-31	Net margin	-184.8%	Net Income: -19489000 Open source Revenue: 10548000 Open source
19971997-12-31	Net margin	-452%	Net Income: -43840000 Open source Revenue: 9700000 Open source
19981998-12-31	Net margin	-675.6%	Net Income: -56609000 Open source Revenue: 8379000 Open source
19991999-12-31	Net margin	-452.4%	Net Income: -49573000 Open source Revenue: 10958000 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -8569000 Open source Capital Expenditure: 6377000 Open source
19951995-12-31	Free cash flow margin	-923.2%	Revenue: 3000000 Open source Operating Cash Flow: -17416000 Open source Capital Expenditure: 10279000 Open source
19961996-12-31	Free cash flow margin	-378.5%	Revenue: 10548000 Open source Operating Cash Flow: -18909000 Open source Capital Expenditure: 21012000 Open source
19971997-12-31	Free cash flow margin	-278.8%	Revenue: 9700000 Open source Operating Cash Flow: -24913000 Open source Capital Expenditure: 2132000 Open source
19981998-12-31	Free cash flow margin	-509.6%	Revenue: 8379000 Open source Operating Cash Flow: -40457000 Open source Capital Expenditure: 2245000 Open source
19991999-12-31	Free cash flow margin	-383.7%	Revenue: 10958000 Open source Operating Cash Flow: -38960000 Open source Capital Expenditure: 3091000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -39M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-8569000	Operating Cash Flow: -8569000 Open source
19951995-12-31	Operating cash flow	-17416000	Operating Cash Flow: -17416000 Open source
19961996-12-31	Operating cash flow	-18909000	Operating Cash Flow: -18909000 Open source
19971997-12-31	Operating cash flow	-24913000	Operating Cash Flow: -24913000 Open source
19981998-12-31	Operating cash flow	-40457000	Operating Cash Flow: -40457000 Open source
19991999-12-31	Operating cash flow	-38960000	Operating Cash Flow: -38960000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -42.1M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-14946000	Operating Cash Flow: -8569000 Open source Capital Expenditure: 6377000 Open source
19951995-12-31	Free cash flow	-27695000	Operating Cash Flow: -17416000 Open source Capital Expenditure: 10279000 Open source
19961996-12-31	Free cash flow	-39921000	Operating Cash Flow: -18909000 Open source Capital Expenditure: 21012000 Open source
19971997-12-31	Free cash flow	-27045000	Operating Cash Flow: -24913000 Open source Capital Expenditure: 2132000 Open source
19981998-12-31	Free cash flow	-42702000	Operating Cash Flow: -40457000 Open source Capital Expenditure: 2245000 Open source
19991999-12-31	Free cash flow	-42051000	Operating Cash Flow: -38960000 Open source Capital Expenditure: 3091000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

392.1% 1999

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
19951995-12-31	Liabilities / assets	19.5%	Total Liabilities: 8051000 Open source Total Assets: 41249000 Open source
19961996-12-31	Liabilities / assets	83.9%	Total Liabilities: 103183000 Open source Total Assets: 122962000 Open source
19971997-12-31	Liabilities / assets	120.5%	Total Liabilities: 101855000 Open source Total Assets: 84508000 Open source
19981998-12-31	Liabilities / assets	191.4%	Total Liabilities: 123499000 Open source Total Assets: 64525000 Open source
19991999-12-31	Liabilities / assets	392.1%	Total Liabilities: 131701000 Open source Total Assets: 33591000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.26× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	1.72×	Current Assets: 13510000 Open source Current Liabilities: 7846000 Open source
19961996-12-31	Current assets / current liabilities	7.07×	Current Assets: 77362000 Open source Current Liabilities: 10948000 Open source
19971997-12-31	Current assets / current liabilities	3.51×	Current Assets: 49171000 Open source Current Liabilities: 13999000 Open source
19981998-12-31	Current assets / current liabilities	2.4×	Current Assets: 29643000 Open source Current Liabilities: 12333000 Open source
19991999-12-31	Current assets / current liabilities	0.26×	Current Assets: 8138000 Open source Current Liabilities: 31064000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 3.93 million Exact value Exact value: -3927000 USD 1994-01-01 – 1994-12-31: -3927000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NORTH AMERICAN VACCINE INC · 1994-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Net Income: -3927000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3927000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-97-000193.txt#3146 The citation records this snapshot. The page link may show a newer release later.	−USD 8.57 million Exact value Exact value: -8569000 USD 1994-01-01 – 1994-12-31: -8569000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NORTH AMERICAN VACCINE INC · 1994-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Operating Cash Flow: -8569000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8569000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-97-000193.txt#3161 The citation records this snapshot. The page link may show a newer release later.	USD 6.38 million Exact value Exact value: 6377000 USD 1994-01-01 – 1994-12-31: 6377000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NORTH AMERICAN VACCINE INC · 1994-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Capital Expenditure: 6377000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6377000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-97-000193.txt#3165 The citation records this snapshot. The page link may show a newer release later.	−USD 14.95 million Calculation and evidence -8569000 − 6377000 USD Exact free cash flow: -14946000 USD 1994-01-01 – 1994-12-31: -8569000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 6377000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NORTH AMERICAN VACCINE INC · 1994-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Free cash flow: -14946000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8569000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-97-000193.txt#3161 Input fundies:CapitalExpenditure: 6377000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-97-000193.txt#3165 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 4.99 million Exact value Exact value: -4986000 USD 1995-01-01 – 1995-12-31: -4986000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NORTH AMERICAN VACCINE INC · 1995-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Net Income: -4986000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4986000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-98-000319.txt#3127 The citation records this snapshot. The page link may show a newer release later.	−USD 17.42 million Exact value Exact value: -17416000 USD 1995-01-01 – 1995-12-31: -17416000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NORTH AMERICAN VACCINE INC · 1995-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Operating Cash Flow: -17416000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17416000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-98-000319.txt#3140 The citation records this snapshot. The page link may show a newer release later.	USD 10.28 million Exact value Exact value: 10279000 USD 1995-01-01 – 1995-12-31: 10279000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NORTH AMERICAN VACCINE INC · 1995-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Capital Expenditure: 10279000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10279000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-98-000319.txt#3144 The citation records this snapshot. The page link may show a newer release later.	−USD 27.7 million Calculation and evidence -17416000 − 10279000 USD Exact free cash flow: -27695000 USD 1995-01-01 – 1995-12-31: -17416000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 10279000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NORTH AMERICAN VACCINE INC · 1995-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Free cash flow: -27695000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17416000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-98-000319.txt#3140 Input fundies:CapitalExpenditure: 10279000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-98-000319.txt#3144 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 19.49 million Exact value Exact value: -19489000 USD 1996-01-01 – 1996-12-31: -19489000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NORTH AMERICAN VACCINE INC · 1996-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Net Income: -19489000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19489000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-99-000085.txt#3408 The citation records this snapshot. The page link may show a newer release later.	−USD 18.91 million Exact value Exact value: -18909000 USD 1996-01-01 – 1996-12-31: -18909000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NORTH AMERICAN VACCINE INC · 1996-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Operating Cash Flow: -18909000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18909000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-99-000085.txt#3423 The citation records this snapshot. The page link may show a newer release later.	USD 21.01 million Exact value Exact value: 21012000 USD 1996-01-01 – 1996-12-31: 21012000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NORTH AMERICAN VACCINE INC · 1996-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Capital Expenditure: 21012000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21012000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-99-000085.txt#3427 The citation records this snapshot. The page link may show a newer release later.	−USD 39.92 million Calculation and evidence -18909000 − 21012000 USD Exact free cash flow: -39921000 USD 1996-01-01 – 1996-12-31: -18909000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 21012000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NORTH AMERICAN VACCINE INC · 1996-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Free cash flow: -39921000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18909000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-99-000085.txt#3423 Input fundies:CapitalExpenditure: 21012000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-99-000085.txt#3427 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 43.84 million Exact value Exact value: -43840000 USD 1997-01-01 – 1997-12-31: -43840000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NORTH AMERICAN VACCINE INC · 1997-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Net Income: -43840000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43840000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4066 The citation records this snapshot. The page link may show a newer release later.	−USD 24.91 million Exact value Exact value: -24913000 USD 1997-01-01 – 1997-12-31: -24913000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NORTH AMERICAN VACCINE INC · 1997-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Operating Cash Flow: -24913000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24913000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085 The citation records this snapshot. The page link may show a newer release later.	USD 2.13 million Exact value Exact value: 2132000 USD 1997-01-01 – 1997-12-31: 2132000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NORTH AMERICAN VACCINE INC · 1997-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Capital Expenditure: 2132000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2132000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089 The citation records this snapshot. The page link may show a newer release later.	−USD 27.05 million Calculation and evidence -24913000 − 2132000 USD Exact free cash flow: -27045000 USD 1997-01-01 – 1997-12-31: -24913000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 2132000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NORTH AMERICAN VACCINE INC · 1997-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Free cash flow: -27045000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24913000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085 Input fundies:CapitalExpenditure: 2132000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 56.61 million Exact value Exact value: -56609000 USD 1998-01-01 – 1998-12-31: -56609000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NORTH AMERICAN VACCINE INC · 1998-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Net Income: -56609000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56609000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4066 The citation records this snapshot. The page link may show a newer release later.	−USD 40.46 million Exact value Exact value: -40457000 USD 1998-01-01 – 1998-12-31: -40457000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NORTH AMERICAN VACCINE INC · 1998-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Operating Cash Flow: -40457000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40457000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085 The citation records this snapshot. The page link may show a newer release later.	USD 2.25 million Exact value Exact value: 2245000 USD 1998-01-01 – 1998-12-31: 2245000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NORTH AMERICAN VACCINE INC · 1998-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Capital Expenditure: 2245000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2245000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089 The citation records this snapshot. The page link may show a newer release later.	−USD 42.7 million Calculation and evidence -40457000 − 2245000 USD Exact free cash flow: -42702000 USD 1998-01-01 – 1998-12-31: -40457000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2245000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NORTH AMERICAN VACCINE INC · 1998-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Free cash flow: -42702000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40457000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085 Input fundies:CapitalExpenditure: 2245000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 49.57 million Exact value Exact value: -49573000 USD 1999-01-01 – 1999-12-31: -49573000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Net Income: -49573000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -49573000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4066 The citation records this snapshot. The page link may show a newer release later.	−USD 38.96 million Exact value Exact value: -38960000 USD 1999-01-01 – 1999-12-31: -38960000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Operating Cash Flow: -38960000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38960000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085 The citation records this snapshot. The page link may show a newer release later.	USD 3.09 million Exact value Exact value: 3091000 USD 1999-01-01 – 1999-12-31: 3091000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Capital Expenditure: 3091000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3091000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089 The citation records this snapshot. The page link may show a newer release later.	−USD 42.05 million Calculation and evidence -38960000 − 3091000 USD Exact free cash flow: -42051000 USD 1999-01-01 – 1999-12-31: -38960000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 3091000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NORTH AMERICAN VACCINE INC · 1999-12-31 NORTH AMERICAN VACCINE INC (edgar:856573) Free cash flow: -42051000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:19:33Z Snapshot: 1b26c6e477b20e3cc5a59da5d7ae0c6f826be6bb76b890fffae05c125f8df8e5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/856573?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38960000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4085 Input fundies:CapitalExpenditure: 3091000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/856573/0000898432-00-000281.txt#4089 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000856573, 856573, edgar:856573

NORTH AMERICAN VACCINE INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1999-01-01 – 1999-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation